{"id":"https://openalex.org/W2601903444","doi":"https://doi.org/10.3851/imp3160","title":"Impact of CCR5, Integrase and Protease Inhibitors on Human Endothelial Cell Function, Stress, Inflammation and Senescence","display_name":"Impact of CCR5, Integrase and Protease Inhibitors on Human Endothelial Cell Function, Stress, Inflammation and Senescence","publication_year":2016,"publication_date":"2016-11-01","ids":{"openalex":"https://openalex.org/W2601903444","doi":"https://doi.org/10.3851/imp3160","mag":"2601903444","pmid":"https://pubmed.ncbi.nlm.nih.gov/28350300"},"language":"en","primary_location":{"id":"doi:10.3851/imp3160","doi":"https://doi.org/10.3851/imp3160","is_oa":false,"landing_page_url":"https://doi.org/10.3851/imp3160","pdf_url":null,"source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021749731","display_name":"Pauline Afonso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210134622","display_name":"Centre de Recherche Saint-Antoine","ror":"https://ror.org/03wxndv36","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210129850","https://openalex.org/I4210134622"]},{"id":"https://openalex.org/I4210154657","display_name":"Fondation pour l\u2019innovation en Cadiom\u00e9tabolisme et Nutrition","ror":"https://ror.org/050c3pq49","country_code":"FR","type":"other","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210154657"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pauline Afonso","raw_affiliation_strings":["ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","institution_ids":["https://openalex.org/I4210154657"]},{"raw_affiliation_string":"Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210134622"]},{"raw_affiliation_string":"Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015410107","display_name":"Martine Auclair","orcid":"https://orcid.org/0000-0003-3600-1999","observed_orcids":["https://orcid.org/0000-0003-3600-1999"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210134622","display_name":"Centre de Recherche Saint-Antoine","ror":"https://ror.org/03wxndv36","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210129850","https://openalex.org/I4210134622"]},{"id":"https://openalex.org/I4210154657","display_name":"Fondation pour l\u2019innovation en Cadiom\u00e9tabolisme et Nutrition","ror":"https://ror.org/050c3pq49","country_code":"FR","type":"other","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210154657"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Martine Auclair","raw_affiliation_strings":["ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","institution_ids":["https://openalex.org/I4210154657"]},{"raw_affiliation_string":"Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210134622"]},{"raw_affiliation_string":"Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111756743","display_name":"Martine Caron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210134622","display_name":"Centre de Recherche Saint-Antoine","ror":"https://ror.org/03wxndv36","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210129850","https://openalex.org/I4210134622"]},{"id":"https://openalex.org/I4210154657","display_name":"Fondation pour l\u2019innovation en Cadiom\u00e9tabolisme et Nutrition","ror":"https://ror.org/050c3pq49","country_code":"FR","type":"other","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210154657"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Martine Caron-Debarle","raw_affiliation_strings":["ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","institution_ids":["https://openalex.org/I4210154657"]},{"raw_affiliation_string":"Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210134622"]},{"raw_affiliation_string":"Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035291390","display_name":"Jacqueline Capeau","orcid":"https://orcid.org/0000-0002-1710-4186","observed_orcids":["https://orcid.org/0000-0002-1710-4186"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210134622","display_name":"Centre de Recherche Saint-Antoine","ror":"https://ror.org/03wxndv36","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210129850","https://openalex.org/I4210134622"]},{"id":"https://openalex.org/I4210154657","display_name":"Fondation pour l\u2019innovation en Cadiom\u00e9tabolisme et Nutrition","ror":"https://ror.org/050c3pq49","country_code":"FR","type":"other","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210154657"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jacqueline Capeau","raw_affiliation_strings":["ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICAN, Institute of Cardiometabolism and Nutrition, Paris, France","institution_ids":["https://openalex.org/I4210154657"]},{"raw_affiliation_string":"Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210134622"]},{"raw_affiliation_string":"Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5035291390"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210134622","https://openalex.org/I4210154657","https://openalex.org/I4405264447"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":1.0208,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.7816033,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"22","issue":"8","first_page":"645","last_page":"657"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.08020000159740448,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccr5-antagonist","display_name":"CCR5 antagonist","score":0.8899999856948853},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9020000100135803},{"id":"https://openalex.org/keywords/endothelial-senescence","display_name":"endothelial cell senescence","score":0.8759999871253967},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":1.0},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.36800000071525574},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.8769999742507935},{"id":"https://openalex.org/keywords/maraviroc","display_name":"maraviroc","score":0.8650000095367432},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atazanavir","display_name":"atazanavir","score":0.7870000004768372},{"id":"https://openalex.org/keywords/darunavir","display_name":"darunavir","score":0.9300000071525574},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.7760000228881836},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.7429999709129333},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.6269999742507935},{"id":"https://openalex.org/keywords/aging","display_name":"aging","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.8490386009216309},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.7875274419784546},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.6925510168075562},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.68222975730896},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.6250318288803101},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.568411111831665},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5650625228881836},{"id":"https://openalex.org/C522857546","wikidata":"https://www.wikidata.org/wiki/Q2070979","display_name":"Senescence","level":2,"score":0.5527108907699585},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.5365213751792908},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.5111520886421204},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.4695468544960022},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3845493793487549},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36091434955596924},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33714407682418823},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2620060443878174},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.1589573621749878},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013312","descriptor_name":"Stress, Physiological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015815","descriptor_name":"Cell Adhesion Molecules","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016922","descriptor_name":"Cellular Senescence","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D065100","descriptor_name":"CCR5 Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3851/imp3160","doi":"https://doi.org/10.3851/imp3160","is_oa":false,"landing_page_url":"https://doi.org/10.3851/imp3160","pdf_url":null,"source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:28350300","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28350300","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-03982913v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.sorbonne-universite.fr/hal-03982913","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antiviral Therapy, 2017, 22 (8), pp.645-657. ⟨10.3851/IMP3160⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W90256038","https://openalex.org/W138587671","https://openalex.org/W1503756158","https://openalex.org/W1578616085","https://openalex.org/W1606409921","https://openalex.org/W1766859729","https://openalex.org/W1767400858","https://openalex.org/W1893714901","https://openalex.org/W1963902614","https://openalex.org/W1967031519","https://openalex.org/W1972230443","https://openalex.org/W1974342821","https://openalex.org/W1995119157","https://openalex.org/W2000460634","https://openalex.org/W2006856548","https://openalex.org/W2008656224","https://openalex.org/W2021128415","https://openalex.org/W2029148240","https://openalex.org/W2032586043","https://openalex.org/W2038881106","https://openalex.org/W2040205289","https://openalex.org/W2052905794","https://openalex.org/W2070027063","https://openalex.org/W2085355921","https://openalex.org/W2095065201","https://openalex.org/W2108455038","https://openalex.org/W2109423206","https://openalex.org/W2127517680","https://openalex.org/W2130458932","https://openalex.org/W2135618827","https://openalex.org/W2144713113","https://openalex.org/W2149357658","https://openalex.org/W2157936114","https://openalex.org/W2158396244","https://openalex.org/W2166633644","https://openalex.org/W2170777065","https://openalex.org/W2211236365","https://openalex.org/W2255326772","https://openalex.org/W2293552644","https://openalex.org/W2329008678","https://openalex.org/W2332434525","https://openalex.org/W2415979752","https://openalex.org/W2443582141","https://openalex.org/W2472650240","https://openalex.org/W2611937689"],"related_works":["https://openalex.org/W2170777065","https://openalex.org/W3002187843","https://openalex.org/W7100181741","https://openalex.org/W2032586043","https://openalex.org/W1989947634","https://openalex.org/W4414142428","https://openalex.org/W6889415971","https://openalex.org/W1990237080","https://openalex.org/W2064812487","https://openalex.org/W6902116808"],"abstract_inverted_index":{"BACKGROUND:":[0],"Ageing":[1],"HIV-infected":[2],"patients":[3],"present":[4],"an":[5,14,123],"increased":[6,187],"incidence":[7],"of":[8,28,36,57,131,169,199],"cardiovascular":[9,29],"diseases,":[10],"endothelial":[11,46,54,69,84,151,172],"dysfunction":[12],"being":[13,91],"early":[15],"alteration.":[16],"Some":[17],"protease":[18],"inhibitors":[19,40],"(PIs)":[20],"have":[21],"been":[22],"shown":[23],"to":[24,43,174,194],"increase":[25],"the":[26,34,110,117,158,163,196],"risk":[27],"disease.":[30],"We":[31,52,154],"evaluated":[32,53],"here":[33,156],"effects":[35,90],"CCR5":[37,164],"or":[38],"integrase":[39,159],"as":[41],"compared":[42],"PIs":[44],"on":[45],"functions":[47,85],"in":[48],"vitro.":[49],"METHODS:":[50],"concentrations.":[51],"function,":[55],"secretion":[56],"adhesion":[58],"molecules":[59],"and":[60,65,78,86,99,113,137,141,147,149,162,189],"cytokines,":[61],"inflammation,":[62,107],"oxidative":[63,144],"stress":[64],"senescence.":[66,132,190],"RESULTS:":[67],"In":[68],"cells":[70,173],"from":[71,122],"adult":[72,171],"donors,":[73],"we":[74],"confirmed":[75],"that":[76,157],"ATV/r":[77],"DRV/r":[79],"adversely":[80],"affected":[81,135],"all":[82],"assessed":[83],"enhanced":[87],"senescence,":[88,114,184],"these":[89,200],"mild":[92,102],"for":[93],"DRV/r.":[94],"Raltegravir":[95,133],"had":[96],"no":[97],"effect":[98],"maraviroc":[100,140,166],"a":[101,128],"anti-inflammatory":[103],"effect.":[104],"Dolutegravir":[105,181],"decreased":[106,143],"by":[108,115],"inhibiting":[109],"NF\u03baB":[111],"pathway,":[112],"repressing":[116],"p21":[118],"pathway.":[119],"Moreover,":[120],"HCAEC":[121],"old":[124],"donor":[125],"presented,":[126],"constitutively,":[127],"high":[129],"level":[130],"mildly":[134],"inflammation":[136,146,168,188],"senescence":[138,148],"while":[139,177,185],"dolutegravir":[142,161],"stress,":[145],"improved":[150],"dysfunction.":[152],"CONCLUSIONS:":[153],"report":[155],"inhibitor":[160,165],"reduced":[167,183],"human":[170],"different":[175],"extents":[176],"raltegravir":[178],"was":[179],"neutral.":[180],"also":[182],"PI/r":[186],"It":[191],"is":[192],"important":[193],"address":[195],"clinical":[197],"relevance":[198],"results.":[201]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-04-07T00:00:00"}